Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Buy” on shares of Bio-Techne as a short-term investment idea. The firm expects Bio-Techne to report fiscal Q3 results in line or above ...

Bio-Techne Corporation TECH recently began shipping the Leo System, powered by Simple Western Technology. Leo offers the throughput and precision of standard ELISAs in a fully automated western blot ...

Keybank National Association OH boosted its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 66.4% in the ...

Bio-Techne was ordered on Feb. 26 by an arbitrator to pay its former CEO Charles Kummeth about $36 million after providing the wrong expiration date on granted options to buy about 779k shares of ...

Bio-Techne Corporation (NASDAQ: TECH) today announced that it has begun shipping the Leo™ System, powered by Simple Western™ Technology. Leo expands upon existing Simple Western platforms that offer ...

StockNews.com cut shares of Bio-Techne (NASDAQ:TECH – Free Report) from a buy rating to a hold rating in a report issued on Monday morning. TECH has been the topic of a number of other research ...

Highlights,Citigroup revised its price target for Bio-Techne, reflecting varied market sentiment.,The company’s stock has ...

Barclays 27th Annual Global Healthcare ConferenceMarch 12, 202510:00 AM EDT A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website ...

MINNEAPOLIS, March 10, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has begun shipping the Leo™ System, powered by Simple Western™ Technology. Leo expands ...

The stock's fall snapped a three-day winning streak.